In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

The immunological mechanisms underlying the susceptibility to disseminated visceral parasitism of mononuclear phagocytes in patients with kala-azar remain undefined. Resistance and susceptibility are correlated with distinct patterns of cytokine production in murine models of disseminated leishmanial disease. To assess lesional cytokine profiles in patients with kala-azar, bone marrow aspirates were analyzed using a quantitative reverse transcriptase PCR technique to amplify specific mRNA sequences of multiple Th1-, Th2-, and/or macrophage-associated cytokines. Transcript levels of IL-10 as well as IFN-gamma were significantly elevated in patients with active visceral leishmaniasis; IL-10 levels decreased markedly with resolution of disease. These findings suggest that IL-10, a potent, pleiotropic suppressor of all known microbicidal effector functions of macrophages, may contribute to the pathogenesis of kala-azar by inhibiting the cytokine-mediated activation of host macrophages that is necessary for the control of leishmanial infection.

[1]  S. Reed,et al.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.

[2]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[3]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[4]  J. Ho,et al.  Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. , 1992, The Journal of infectious diseases.

[5]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[6]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[7]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[8]  A. Sher,et al.  Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. , 1991, Journal of immunology.

[9]  F. Finkelman,et al.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. , 1991, Journal of immunology.

[10]  DianaN. J. Lockwood.  Sudan: Kala-azar should be in the news , 1991, The Lancet.

[11]  R. Locksley,et al.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Blackwell,et al.  Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. , 1991, Journal of immunology.

[13]  F. Liew,et al.  Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis. , 1991, Journal of immunology.

[14]  T. Mosmann,et al.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.

[15]  R. Locksley,et al.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism , 1990, The Journal of experimental medicine.

[16]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[17]  Miguel Ángel Martínez,et al.  Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. , 1989, Reviews of infectious diseases.

[18]  P. Scott.  The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis. , 1989, Experimental parasitology.

[19]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[20]  M. Sporn,et al.  Deactivation of macrophages by transforming growth factor-β , 1988, Nature.

[21]  M. Sporn,et al.  Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[23]  D. Sacks,et al.  An analysis of T cell responsiveness in Indian kala-azar. , 1987, Journal of immunology.

[24]  S. Reed,et al.  Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. , 1985, The Journal of clinical investigation.

[25]  H. Murray,et al.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. , 1983, The Journal of clinical investigation.

[26]  W. Johnson,et al.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection , 1981, Infection and immunity.

[27]  K. Wiktorowicz,et al.  [Biological properties of interleukin 10]. , 1994, Postepy higieny i medycyny doswiadczalnej.

[28]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.